1.
J Neuroimmunol
; 133(1-2): 56-9, 2002 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12446008
RESUMO
Leukemia inhibitory factor (LIF) is a pleiotropic cytokine that exerts neurotrophic and myotrophic actions. We have investigated the effect of LIF in experimental autoimmune neuritis (EAN), an animal model of Guillain-Barré syndrome (GBS). Treatment with LIF at the onset of the disease showed a slight, but not significant, improvement in the clinical course but no effect on nerve histology.
